Patents by Inventor Kevin Millsap

Kevin Millsap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated Bordetella Bronchiseptica Strains, Oral Vaccines Containing the Attenuated Strains, and Methods of Making & Use Thereof
    Publication number: 20220054616
    Abstract: The present invention provides attenuated, aroA mutant B. bronchiseptica strains that are effective to elicit an immune response in an animal against B. bronchiseptica. Also provided are immunogenic compositions and vaccines which include the attenuated, aroA mutant B. bronchiseptica strains. Also provided are kits for use with such compositions and vaccines. Also provided are methods of orally administering attenuated, aroA mutant B. bronchiseptica strains, compositions, and vaccines to animals.
    Type: Application
    Filed: January 6, 2020
    Publication date: February 24, 2022
    Inventors: Laurent Bernard FISCHER, Edmond JOLIVET, Kevin MILLSAP
  • PROCESS FOR THE PRODUCTION OF FILAMENTOUS BACTERIOPHAGE
    Publication number: 20140220660
    Abstract: The invention relates to culture conditions and methods that allow reproducible production of high titers of filamentous bacteriophage. Culture media comprising high titers of filamentous bacteriophage, as we methods of producing high titers of filamentous phage on a large scale are encompassed.
    Type: Application
    Filed: July 27, 2012
    Publication date: August 7, 2014
    Inventors: Jason Wright, Marc Bradford, Frank Sugar, Tim Davies, Kevin Millsap